[go: up one dir, main page]

BR9609631A - 1,6-disubstituted isochromans for the treatment of migraine headaches - Google Patents

1,6-disubstituted isochromans for the treatment of migraine headaches

Info

Publication number
BR9609631A
BR9609631A BR9609631A BR9609631A BR9609631A BR 9609631 A BR9609631 A BR 9609631A BR 9609631 A BR9609631 A BR 9609631A BR 9609631 A BR9609631 A BR 9609631A BR 9609631 A BR9609631 A BR 9609631A
Authority
BR
Brazil
Prior art keywords
isochromans
disubstituted
treatment
migraine headaches
headaches
Prior art date
Application number
BR9609631A
Other languages
Portuguese (pt)
Inventor
Ruth E Tenbrink
Michael D Enis
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR9609631A publication Critical patent/BR9609631A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9609631A 1995-06-30 1996-06-07 1,6-disubstituted isochromans for the treatment of migraine headaches BR9609631A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06
PCT/US1996/008681 WO1997002259A1 (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromans for treatment of migraine headaches

Publications (1)

Publication Number Publication Date
BR9609631A true BR9609631A (en) 1999-03-02

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609631A BR9609631A (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromans for the treatment of migraine headaches

Country Status (12)

Country Link
EP (1) EP0836599A1 (en)
JP (1) JPH11509532A (en)
AU (1) AU6252296A (en)
BR (1) BR9609631A (en)
CA (1) CA2225282A1 (en)
CZ (1) CZ418597A3 (en)
FI (1) FI974640L (en)
MX (1) MX9710260A (en)
NO (1) NO976112L (en)
PL (1) PL324319A1 (en)
SK (1) SK164297A3 (en)
WO (1) WO1997002259A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
BRPI0510642A (en) 2004-05-05 2007-11-20 Hoffmann La Roche arylsulfonyl benzodioxanes useful for modulating 5-ht6 receptor, 5ht2a receptor or both
CN101119989B (en) 2004-12-21 2010-06-09 弗·哈夫曼-拉罗切有限公司 Seman derivatives and their use in the treatment of CNS diseases
AU2005318596B2 (en) 2004-12-21 2010-12-23 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-HT receptor ligands
ES2314749T3 (en) 2004-12-21 2009-03-16 F. Hoffmann-La Roche Ag DERIVATIVES OF TETRALINA AND INDANO AND USES OF THE SAME AS 5-HT ANTAGONISTS.
KR100899061B1 (en) 2004-12-21 2009-05-25 에프. 호프만-라 로슈 아게 Tetralin and indane derivatives and uses thereof
PL1831159T3 (en) 2004-12-21 2010-06-30 Hoffmann La Roche Tetralin and indane derivatives and uses thereof
RU2008115032A (en) 2005-11-03 2009-12-10 Ф. Хоффманн-Ля Рош Аг (Ch) ARILSULFONILCHROMANES AS 5-NT6 INHIBITORS
EP2041079A1 (en) 2006-06-20 2009-04-01 F. Hoffmann-Roche AG Arylsulfonyl naphthalene derivatives and uses thereof
CA2655524A1 (en) 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN102341367B (en) * 2009-03-05 2014-05-07 住友化学株式会社 Method for producing halogen-substituted benzene dimethanol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
NZ277373A (en) * 1993-12-28 1998-07-28 Upjohn Co Iso(thio)chroman-1-ylethylpiperazine and -piperidine derivatives (analogues)

Also Published As

Publication number Publication date
MX9710260A (en) 1998-03-29
NO976112D0 (en) 1997-12-29
FI974640A7 (en) 1997-12-30
CZ418597A3 (en) 1998-06-17
WO1997002259A1 (en) 1997-01-23
FI974640A0 (en) 1997-12-30
FI974640L (en) 1997-12-30
AU6252296A (en) 1997-02-05
SK164297A3 (en) 1998-09-09
CA2225282A1 (en) 1997-01-23
NO976112L (en) 1998-03-02
EP0836599A1 (en) 1998-04-22
PL324319A1 (en) 1998-05-25
JPH11509532A (en) 1999-08-24

Similar Documents

Publication Publication Date Title
NO981800D0 (en) Process for the preparation of 1,1,1,3,3-pentafluoropentane
ZA97631B (en) Migraine treatment.
BR9609631A (en) 1,6-disubstituted isochromans for the treatment of migraine headaches
DE69515997D1 (en) TRANSCODER
FI20011433L (en) Process for the preparation of 2,5,diamino-4,6-dichloropyrimidine
AU2825295A (en) Method for the treatment, prevention or minimization of hair loss
IT1292552B1 (en) DEVICE FOR THE APPLICATION OF COATINGS.
BR9605759A (en) Continuous process for the preparation of 4-mino-2,2,6,6-tetramethylpiperidine
EP1023250A4 (en) PROCESS FOR THE PREPARATION OF 2,6-DIALKYLNAPHTALENE
IT1303677B1 (en) DEVICE FOR THE HEAT TREATMENT OF PIECES.
PT928183E (en) USES OF 1-HYDROXYL-2-PYRIDONENE FOR THE TREATMENT OF SEBORROIC DERMATITIS
FI972058A0 (en) For the purposes of this Regulation, this Regulation shall apply
DK0815092T3 (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
NO985535L (en) Process for the preparation of 1,3-alkanediols
FI964278L (en) Process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives
IT1277680B1 (en) PROCEDURE FOR THE ALKYLATION OF AROMATIC COMPOUNDS
ID16434A (en) COMPOUNDS OF 1,4-DIHYDROPIRIDINS
ZA965548B (en) 1,6-disubstituted isochromans for treatment of migraine headaches
HUP9802226A3 (en) 1,6-disubstituted isochromans for treatment of migraine headaches
FI940088A0 (en) Regulation / Regulation For the purposes of this Regulation, the provisions of this Regulation shall apply
FI970039A7 (en) Process for the preparation of 5-aryl-2,4-dialkyl-3H-1,2,3-triazole-3-thiones
DK0737068T3 (en) 2,3-diaryl-1-benzopyrans for the treatment of dermatitis
ES1029021Y (en) LONG FOR THE FORMATION OF SHELVES.
ITTV940061A0 (en) "PAGE, PARTICULARLY FOR THE PRACTICE OF FENCING".
FI941868A0 (en) For the purposes of this Regulation, the provisions of this Regulation shall apply.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law